Viela Bio, Inc. | Purchase Agreements | Business Contracts

License Agreement, by and between Duke University and Cellective Therapeutics, Inc., dated September 21, 2004 as amended by the Letter Agreement dated September 9, 2005 (assigned... (Filed With SEC on August 29, 2019)

License Agreement by and between Dana-Farber Cancer Institute, Inc. and Cellective Therapeutics, Inc., as amended, dated December 21, 2004 as amended by the Letter Agreement dated... (Filed With SEC on August 29, 2019)

License Agreement between SBI Biotech Co. Ltd. and MedImmune, LLC, dated as of September 9, 2008 (assigned to the Registrant pursuant to the Asset Purchase Agreement by and... (Filed With SEC on August 29, 2019)

Asset Purchase Agreement, by and between the Registrant and MedImmune, LLC, MedImmune Limited and AstraZeneca Collaboration Ventures, LLC, dated as of February 23, 2018 (Filed With SEC on August 29, 2019)

Viela Bio, Inc. (36) | Purchase Agreements (4)